Outlook Therapeutics, Inc. (OTLK)
0.4131
-0.02
(-4.95%)
USD |
NASDAQ |
Feb 20, 16:00
0.41
0.00 (0.00%)
After-Hours: 20:00
Outlook Therapeutics SG&A Expense (Quarterly) : 8.612M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 21.91M |
| Amicus Therapeutics, Inc. | 117.08M |
| Neogen Corp. | 107.50M |
| CorMedix, Inc. | 36.64M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |